Evidence map›Paper›PMID 30002797›Full record

ArticleMediterranean journal of hematology and infectious diseases2018

Impact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina Faso.

Arzouma Paul Yooda, Serge Theophile Soubeiga, K Yacouba Nebie, Birama Diarra, Salam Sawadogo, Abdoul Karim Ouattara, Dorcas Obiri-Yeboah, Albert Theophane Yonli, Issoufou Tao, Pegdwende Abel Sorgho and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Arzouma Paul YoodaLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Serge Theophile SoubeigaLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
K Yacouba NebieNational Blood Transfusion Center (CNTS), 01 BP 5372 Ouagadougou 01, Burkina Faso.
Birama DiarraLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Salam SawadogoNational Blood Transfusion Center (CNTS), 01 BP 5372 Ouagadougou 01, Burkina Faso.
Abdoul Karim OuattaraLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Dorcas Obiri-YeboahDepartment of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Ghana.
Albert Theophane YonliLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Issoufou TaoLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Pegdwende Abel SorghoLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Honorine DahourouNational Blood Transfusion Center (CNTS), 01 BP 5372 Ouagadougou 01, Burkina Faso.
Jacques SimporeLaboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof. Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Université Joseph Ki-Zerbo · BFUniversity of Cape Coast · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe improved performance of serological tests has significantly reduced the risk of human immunodeficiency and hepatitis B and C viruses transmission by blood transfusion, but there is a persistence of residual risk. The objective of this study was to evaluate the impact of multiplex PCR in reducing the risk of residual transmission of these viruses in seronegative blood donors in Burkina Faso.

methodsThis cross-sectional study was conducted from March to September 2017. The serological tests were performed on sera using ARCHITECT

resultsA total of 989 donors aged 17 to 65 were included in the present study. "Repeat donors" accounted for 44.79% (443/989). Seroprevalences for HIV, HBV, and HCV were 2.53% (25/989), 7.28% (72/989) and 2.73% (27/989), respectively. Of the 14 co-infections detected, HBV/HCV was the most common with 0.71% (7/989) of cases. Of 808 donations tested by multiplex PCR, 4.70% (38/808) were positive for HBV while no donation was positive for HIV or HCV.

conclusionOur study showed a high residual risk of HBV transmission through blood transfusion. Due to the high prevalence of blood-borne infections in Burkina Faso, we recommend the addition of multiplex PCR to serologic tests for optimal blood donation screening.

Indexed as

Burkina FasoHBVHCVHIVmultiplex PCRTransfusion

Identifiers

PMID30002797
PMCPMC6039083
OpenAlexW2811053827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.